Pharmaceutical Information |
Drug Name |
Etomidate |
Drug ID |
BADD_D00851 |
Description |
Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic. |
Indications and Usage |
Used in the induction of general anesthesia. |
Marketing Status |
approved |
ATC Code |
N01AX07 |
DrugBank ID |
DB00292
|
KEGG ID |
D00548
|
MeSH ID |
D005045
|
PubChem ID |
667484
|
TTD Drug ID |
D02YPG
|
NDC Product Code |
65145-127; 72572-160; 63804-2400; 25021-674; 0143-9507; 68382-545; 0409-6695; 51504-0012; 55150-221; 55150-222; 65219-445; 67457-902; 23155-160; 51662-1485; 65145-128; 51662-1542; 65841-818; 0404-9811; 0143-9506; 65219-447; 67457-903; 63660-0005; 0143-9310; 0143-9311; 72572-161 |
UNII |
Z22628B598
|
Synonyms |
Etomidate | Ethomidate | Radenarkon | Hypnomidate | R-26490 | R 26490 | R26490 |
|
Chemical Information |
Molecular Formula |
C14H16N2O2 |
CAS Registry Number |
33125-97-2 |
SMILES |
CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2 |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|